BUY Zydus Lifesciences — Nilesh Jain, 26 Oct 2026

BUYZydus Lifesciences Limited

Zydus Lifesciences share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: 1–3 months26 Oct 2026via NDTV Profit

Entry₹1,150.9Inferred

Target₹1,200

Total upside +4.27%

Stop loss₹1,100-4.42% risk

CMP₹1,172.9Just now

Active+1.91%+2.31%upside left 3 mo left

Follow Nilesh Jain for new calls(43% target hit, 47 closed calls)Get alerts Watch ZYDUSLIFE for new buy/sell callsGet alerts See 25 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 27 Oct, 4:10 pm IST

11 supporting2 neutral6 opposing

Supports the BUY call (11)

6 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·27 Oct · today

Zydus Lifesciences' subsidiary Zylidac Bio has partnered with Prolific Machines to scale a biologics manufacturing platform to GMP production.

BSE · Company Update·21 Oct · 5d ago

Zydus Lifesciences received USFDA approval for Estradiol and Levonorgestrel Transdermal System, qualifying for 180-day competitive generic therapy exclusivity.

BSE · Company Update·21 Oct · 6d ago

Zydus Lifesciences received USFDA approval for its Estradiol and Levonorgestrel Transdermal System, qualifying for 180-day competitive generic therapy exclusivity.

NSE · Press Release·21 Oct · 6d ago

Zydus Sunshine Lifesciences has signed an agreement with the Sri Lankan Board of Investment to set up a pharmaceutical manufacturing facility.

BSE · Company Update·15 Oct · 2w ago

Neutral / worth noting (2)

Q2 FY27 results scheduled — board meets 04 Nov 2026

BSE · Board Meeting·In 8 days

Zydus hits 52-week high, can the optimism continue?

NewsLivemint·29 Sept · 4w ago

Weighs against the BUY call (6)

MACD below its signal line — bearish momentum

Technicals · macd·27 Oct · today

Zydus Lifesciences In Focus As US FDA Flags Data Integrity, Quality Control Issues At Gujarat Plant

NewsNdtv-Profit·26 Oct · yesterday

Zydus Lifesciences' USFDA inspection at Ahmedabad plant concludes with 5 observations

NewsCnbc-Tv18·13 Oct · 2w ago

The USFDA concluded an inspection of Zydus Lifesciences' Moraiya manufacturing plant with 5 observations, which the company intends to address.

NSE · Press Release·13 Oct · 2w ago

The USFDA concluded an inspection of the company's Moraiya manufacturing plant with 5 observations.

BSE · Company Update·13 Oct · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Nilesh Jain, Centrum Broking

Every call and its outcome

BUY Zydus Lifesciences Limited — Nilesh Jain, Centrum Broking

AI Assessment

Other calls on Zydus Lifesciences

More from Nilesh Jain, Centrum Broking